BRPI0818719A2 - Composição para o tratamento de doença articular - Google Patents

Composição para o tratamento de doença articular

Info

Publication number
BRPI0818719A2
BRPI0818719A2 BRPI0818719A BRPI0818719A2 BR PI0818719 A2 BRPI0818719 A2 BR PI0818719A2 BR PI0818719 A BRPI0818719 A BR PI0818719A BR PI0818719 A2 BRPI0818719 A2 BR PI0818719A2
Authority
BR
Brazil
Prior art keywords
treatment
composition
joint disease
disease
joint
Prior art date
Application number
Other languages
English (en)
Inventor
Norimasa Iwasaki
Akio Minami
Yasuhiko Kasahara
Tatsuya Igarashi
Daisuke Kawamura
Nobuo Ohzawa
Mariko Imai
Original Assignee
Mochida Pharm Co Ltd
Univ Hokkaido Nat Univ Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/JP2008/052999 external-priority patent/WO2008102855A1/ja
Application filed by Mochida Pharm Co Ltd, Univ Hokkaido Nat Univ Corp filed Critical Mochida Pharm Co Ltd
Publication of BRPI0818719A2 publication Critical patent/BRPI0818719A2/pt
Publication of BRPI0818719B1 publication Critical patent/BRPI0818719B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/734—Alginic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/24—Materials or treatment for tissue regeneration for joint reconstruction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0818719A 2007-10-24 2008-08-19 composição para o tratamento de doença articular BRPI0818719B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2007277005 2007-10-24
PCT/JP2008/052999 WO2008102855A1 (ja) 2007-02-21 2008-02-21 軟骨疾患治療用組成物
PCT/JP2008/065065 WO2009054181A1 (ja) 2007-10-24 2008-08-19 関節疾患治療用組成物

Publications (2)

Publication Number Publication Date
BRPI0818719A2 true BRPI0818719A2 (pt) 2015-05-05
BRPI0818719B1 BRPI0818719B1 (pt) 2018-09-04

Family

ID=40579288

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0818719A BRPI0818719B1 (pt) 2007-10-24 2008-08-19 composição para o tratamento de doença articular

Country Status (11)

Country Link
EP (1) EP2210621B1 (pt)
JP (1) JP5491866B2 (pt)
KR (1) KR101510494B1 (pt)
CN (1) CN101835501B (pt)
AU (1) AU2008315175B2 (pt)
BR (1) BRPI0818719B1 (pt)
CA (1) CA2703158C (pt)
ES (1) ES2427730T3 (pt)
MX (1) MX2010004484A (pt)
NZ (1) NZ584869A (pt)
WO (1) WO2009054181A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012085609A1 (en) * 2010-12-20 2012-06-28 Dept. Of Pathobiology Treatment of osteoarthritis by continuous intra-articular injection of alginate gel
CA2846033A1 (en) * 2011-08-23 2013-02-28 Mochida Pharmaceutical Co., Ltd Composition for regeneration of cartilage
WO2014084427A1 (ko) * 2012-11-30 2014-06-05 주식회사 이코바이오 알긴산을 포함하는 골관절염 예방 또는 치료용 조성물
RU2018112431A (ru) * 2015-09-07 2019-10-09 Мотида Фармасьютикал Ко., Лтд. Лиофилизированный препарат альгиновой кислоты
CA3049838A1 (en) * 2017-01-26 2018-08-02 Aboca S.P.A. Societa Agricola New compositions for the treatment of articular disorders
JP7191007B2 (ja) * 2017-03-02 2022-12-16 持田製薬株式会社 線維軟骨組織損傷治療用組成物
JP7570809B2 (ja) * 2017-03-07 2024-10-22 持田製薬株式会社 アルギン酸液剤
CN112154158A (zh) 2018-03-22 2020-12-29 持田制药株式会社 连接有非甾体抗炎化合物的海藻酸衍生物
WO2022102093A1 (ja) * 2020-11-13 2022-05-19 国立大学法人北海道大学 椎間板性疼痛抑制用組成物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589591A (en) 1986-07-03 1996-12-31 Advanced Magnetics, Inc. Endotoxin-free polysaccharides
WO1993013136A1 (en) 1991-12-20 1993-07-08 Howmedica Inc. Ultra-pure polysaccharide materials for medical use
JPH08269102A (ja) 1995-03-30 1996-10-15 Shiseido Co Ltd エンドトキシンフリーのβ１，３−グルカン及びその製造法並びに医療用ゲル素材
JPH09324001A (ja) 1996-04-02 1997-12-16 Kyowa Hakko Kogyo Co Ltd ヒアルロン酸ナトリウムの精製法
US6451772B1 (en) * 1998-11-13 2002-09-17 Monsanto Company Biopolymer salts with low endotoxin levels, biopolymer compositions thereof and methods of making the same
US7005274B1 (en) 1999-09-15 2006-02-28 Migenix Corp. Methods and compositions for diagnosing and treating arthritic disorders and regulating bone mass
TW200307011A (en) * 2002-04-18 2003-12-01 Chugai Pharmaceutical Co Ltd Hyaluronic acid modifier
JP2005036036A (ja) 2003-07-16 2005-02-10 Tanabe Seiyaku Co Ltd エンドトキシン除去方法
EP1799232B1 (en) * 2004-10-12 2015-10-07 FMC Biopolymer AS Self-gelling alginate systems and uses thereof
JP5100980B2 (ja) * 2005-05-18 2012-12-19 株式会社クラレ 化学物質の精製方法
JP4986273B2 (ja) * 2005-09-15 2012-07-25 持田製薬株式会社 アルギン酸を含む創傷被覆材
US20100227804A1 (en) * 2006-01-18 2010-09-09 The University Of Tokyo Gel-forming composition for medical use, administration device for the composition, and drug release controlling carrier
JP4838178B2 (ja) 2006-03-17 2011-12-14 京セラミタ株式会社 画像形成装置

Also Published As

Publication number Publication date
MX2010004484A (es) 2010-07-06
CN101835501B (zh) 2013-07-17
CA2703158C (en) 2016-11-15
AU2008315175A1 (en) 2009-04-30
WO2009054181A1 (ja) 2009-04-30
BRPI0818719B1 (pt) 2018-09-04
CA2703158A1 (en) 2009-04-30
EP2210621A1 (en) 2010-07-28
AU2008315175B2 (en) 2013-12-12
ES2427730T3 (es) 2013-10-31
KR20100088687A (ko) 2010-08-10
EP2210621A4 (en) 2010-11-17
CN101835501A (zh) 2010-09-15
JP5491866B2 (ja) 2014-05-14
KR101510494B1 (ko) 2015-04-08
JPWO2009054181A1 (ja) 2011-03-03
NZ584869A (en) 2011-07-29
EP2210621B1 (en) 2013-07-24

Similar Documents

Publication Publication Date Title
BRPI0818799A2 (pt) Composições para o tratamento da doença de parkinson
BRPI0813725A2 (pt) Métodos e composições para tratamento de doenças
BRPI1012116A2 (pt) composição farmacêutica para o tratamento de doenças cardíacas
BRPI0816784A2 (pt) Fatores neuro-endócrinos para o tratamento de doenças degenerativas
BRPI0916862A2 (pt) compostos úteis para o tratamento de doenças degenerativas e inflamatórias
BRPI1015569A2 (pt) compostos úteis para o tratamento de doenças degenerativas e inflamatórias.
PL3354276T3 (pl) Kompozycje do leczenia zapalenia przewodu pokarmowego
BRPI0716844A2 (pt) Inidores de quinase úteis para o tratamento de doenças proliferativas
IL230335A (en) A drug used to treat cartilage disease
BRPI0813352A2 (pt) Composições de fragmento de tecido para o tratamento de incontinência
PT2367561E (pt) Composições e métodos para o tratamento da doença celíaca
BRPI0817096A2 (pt) análogos de tiazolidinodiona para o tratamento de hipertensão
BRPI0813425A2 (pt) Junção de sangria
BRPI0818719A2 (pt) Composição para o tratamento de doença articular
BRPI0908026A2 (pt) Métodos para o tratamento de doenças do intestino
BRPI1009920A2 (pt) composições bacterianas para profilaxina e tratamento de doença degenerativa.
LT2478907T (lt) Kompozicijos vėžiui gydyti
CR10245A (es) "nuevas combinaciones terapéuticas para el tratamiento de la depresión"
PT2056814E (pt) Compostos de 2,5-di-hidroxibenzeno para o tratamento da psoríase
BRPI0813670A2 (pt) Compostos para tratamento
BRPI0914410A2 (pt) composição de polidesoxirribonucleotídeo injetável para o tratamento de doenças osteoarticulares.
PT2205720T (pt) Composições para tratamento de esclerose múltipla
ZA200805761B (en) Pharmaceutical composition for the treatment of nail disease
PT2056804E (pt) Utilização de derivados de 2,5-di-hidroxibenzeno para o tratamento de doenças oculares
BRPI0914454A2 (pt) "composição para o tratamento do tecido epitelial"

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law
B07E Notice of approval relating to section 229 industrial property law
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B09A Decision: intention to grant
B16A Patent or certificate of addition of invention granted

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 04/09/2018, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 12A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2595 DE 29-09-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.